PharmOptimaâ„¢ Revenue and Competitors
Estimated Revenue & Valuation
- PharmOptimaâ„¢'s estimated annual revenue is currently $7M per year.
- PharmOptimaâ„¢'s estimated revenue per employee is $201,000
Employee Data
- PharmOptimaâ„¢ has 35 Employees.
- PharmOptimaâ„¢ grew their employee count by -3% last year.
PharmOptimaâ„¢'s People
Name | Title | Email/Phone |
---|---|---|
1 | Facility Manager | Reveal Email/Phone |
2 | Business Development Manager | Reveal Email/Phone |
3 | Operations Manager | Reveal Email/Phone |
4 | Research Scientist | Reveal Email/Phone |
5 | Research Associate | Reveal Email/Phone |
6 | Research Associate | Reveal Email/Phone |
PharmOptimaâ„¢ Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $67.1M | 267 | 6% | $10.8M | N/A |
#2 | $7.8M | 39 | 8% | N/A | N/A |
#3 | $5M | 25 | 4% | N/A | N/A |
#4 | $12.7M | 63 | -6% | N/A | N/A |
#5 | $16.5M | 82 | -4% | N/A | N/A |
#6 | $59.5M | 296 | 7% | N/A | N/A |
#7 | $96.2M | 342 | 29% | $764.2M | N/A |
#8 | $6.8M | 34 | 10% | N/A | N/A |
#9 | $5.4M | 27 | -4% | N/A | N/A |
#10 | $8.2M | 41 | 5% | N/A | N/A |
What Is PharmOptimaâ„¢?
PharmOptima™, a member of Genesis Biotechnology Group® (GBG), has been advancing drug discovery and development in various therapeutic areas and has filled a niche in ocular drug development since 2003. PharmOptima’s in vivo services include studies in the fields of drug absorption, distribution, metabolism, and excretion (ADME), pharmacokinetics (PK), and pharmacology. It provides liquid chromatography and mass spectrometry (LC-MS/MS) bioanalysis in support of discovery and development programs, including method development and validation in accordance with regulatory guidelines. Its biochemistry expertise allows them to assess the role of biomarkers in numerous disease models. PharmOptima’s biochemical capabilities include in vitro and cell based assay development for compound profiling as well as protein cloning and expression. Its expertise extends to the custom development of enzyme-linked immunosorbent assays (ELISA) and electrochemiluminescence multiplex formats.
keywords:N/AN/A
Total Funding
35
Number of Employees
$7M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 35 | -5% | N/A |
#2 | $6.9M | 35 | -5% | N/A |
#3 | $7.4M | 38 | 9% | N/A |
#4 | $5.3M | 38 | 12% | N/A |
#5 | $8.4M | 39 | 8% | N/A |